Potential role for statins in the treatment of chronic HCV infection

被引：4
|
作者：
Zhu, Qianqian [1 ]
Han, Qunying [1 ]
Liu, Zhengwen [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China
来源：
FUTURE VIROLOGY | 2013年 / 8卷 / 08期
关键词：
chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;
D O I：
10.2217/fvl.13.70
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
  • [21] Role of ribavirin in HCV treatment response: now and in the future
    Jain, Mamta K.
    Zoellner, Cindy
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 673 - 683
  • [22] Potential role of statins in the treatment of heart failure
    Stuart D. Katz
    Current Atherosclerosis Reports, 2008, 10
  • [23] Optimal treatment with telaprevir for chronic HCV infection
    Jesudian, Arun B.
    Jacobson, Ira M.
    LIVER INTERNATIONAL, 2013, 33 : 3 - 13
  • [24] Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naive or prior relapsers to peginterferon alfa-2a/ribavirin
    Santagostino, E.
    Pol, S.
    Olveira, A.
    Reesink, H. W.
    van Erpecum, K.
    Bogomolov, P.
    Xu, D.
    Critelli, L.
    Srinivasan, S.
    Cooney, E.
    HAEMOPHILIA, 2016, 22 (05) : 692 - 699
  • [25] Therapeutic response in children with post malignancy chronic HCV genotype 1 infection
    Urganci, Nafiye
    Gulec, Seda Geylani
    Polat, Tugcin Bora
    Vural, Sema
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2009, 44 (02): : 68 - 72
  • [26] Telaprevir for Previously Treated Chronic HCV Infection.
    McHutchison, John G.
    Manns, Michael P.
    Muir, Andrew J.
    Terrault, Norah A.
    Jacobson, Ira M.
    Afdhal, Nezam H.
    Heathcote, E. Jenny
    Zeuzem, Stefan
    Reesink, Hendrik W.
    Garg, Jyotsna
    Bsharat, Mohammad
    George, Shelley
    Kauffman, Robert S.
    Adda, Nathalie
    Di Bisceglie, Adrian M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14) : 1292 - 1303
  • [27] The role of HCV proteins on treatment outcomes
    Kumthip, Kattareeya
    Maneekarn, Niwat
    VIROLOGY JOURNAL, 2015, 12
  • [28] Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
    Orr, Cody
    Xu, Wenjie
    Masur, Henry
    Kottilil, Shyam
    Meissner, Eric G.
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [29] Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment
    Hanno, Abd El-Fatah Fahmy
    Mohiedeen, Khaled Mahmoud
    Deghedy, Akram
    Sayed, Reeham
    ARAB JOURNAL OF GASTROENTEROLOGY, 2014, 15 (02) : 58 - 62
  • [30] Developments in the treatment of HCV genotype 3 infection
    McPhee, Fiona
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (10) : 775 - 785
12345